Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

The Coping with Attention and Memory Complaints Questionnaire (CAMQ): psychometric evaluation of an instrument in suspected chronic solvent-induced encephalopathy (CSE).

Visser I, de Boer AG, Wekking EM, van Vliet J, Van Hout MS, Schmand B, van der Laan G, Schene AH, van Dijk FJ.

Neuropsychol Rehabil. 2012;22(5):794-808.

PMID:
22992188
2.

Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.

Verberk MM, van der Hoek JA, van Valen E, Wekking EM, van Hout MS, Hageman G, van der Laan G, van Dijk FJ.

Neurotoxicology. 2012 Aug;33(4):742-52. doi: 10.1016/j.neuro.2012.06.005. Epub 2012 Jun 18.

PMID:
22722000
3.

Cognitive functioning in euthymic recurrently depressed patients: relationship with future relapses and prior course of disease.

Wekking EM, Bockting CL, Koeter MW, Schene AH.

J Affect Disord. 2012 Dec 10;141(2-3):300-7. doi: 10.1016/j.jad.2012.03.034. Epub 2012 May 19.

PMID:
22613451
4.

Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.

van Valen E, van Thriel C, Akila R, Nilson LN, Bast-Pettersen R, Sainio M, van Dijk F, van der Laan G, Verberk M, Wekking E.

Neurotoxicology. 2012 Aug;33(4):710-26. doi: 10.1016/j.neuro.2012.03.010. Epub 2012 Apr 4. Review.

PMID:
22498091
5.

Treatment effect modifiers for the patient education programme for Parkinson's disease.

A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, Stijnen T, Roos RA.

Int J Clin Pract. 2012 Jan;66(1):77-83. doi: 10.1111/j.1742-1241.2011.02791.x.

PMID:
22171907
6.

Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE).

Visser I, Wekking EM, de Boer AG, de Joode EA, van Hout MS, van Dorsselaer S, Ruhé HG, Huijser J, van der Laan G, van Dijk FJ, Schene AH.

Neurotoxicology. 2011 Dec;32(6):916-22. doi: 10.1016/j.neuro.2011.05.001. Epub 2011 May 13.

PMID:
21609732
7.

Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study.

Bockting CL, Spinhoven P, Wouters LF, Koeter MW, Schene AH; DELTA Study Group.

J Clin Psychiatry. 2009 Dec;70(12):1621-8. doi: 10.4088/JCP.08m04784blu.

PMID:
20141705
8.

The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers.

A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, Le Cessie S, Roos RA.

Parkinsonism Relat Disord. 2010 Feb;16(2):89-95. doi: 10.1016/j.parkreldis.2009.07.009. Epub 2009 Aug 11.

PMID:
19674927
9.

The course of chronic solvent induced encephalopathy: a systematic review.

van Valen E, Wekking E, van der Laan G, Sprangers M, van Dijk F.

Neurotoxicology. 2009 Nov;30(6):1172-86. doi: 10.1016/j.neuro.2009.06.002. Epub 2009 Jun 16. Review.

PMID:
19538991
10.

Health related quality of life in recurrent depression: a comparison with a general population sample.

ten Doesschate MC, Koeter MW, Bockting CL, Schene AH; DELTA Study Group.

J Affect Disord. 2010 Jan;120(1-3):126-32. doi: 10.1016/j.jad.2009.04.026. Epub .

PMID:
19446342
11.

Psychosocial and cognitive rehabilitation of patients with solvent-induced chronic toxic encephalopathy: a randomised controlled study.

van Hout MS, Wekking EM, Berg IJ, Deelman BG.

Psychother Psychosom. 2008;77(5):289-97. doi: 10.1159/000140088. Epub 2008 Jun 18.

PMID:
18560254
12.

Cerebral impairment in chronic solvent-induced encephalopathy.

Visser I, Lavini C, Booij J, Reneman L, Majoie C, de Boer AG, Wekking EM, de Joode EA, van der Laan G, van Dijk FJ, Schene AH, Den Heeten GJ.

Ann Neurol. 2008 May;63(5):572-80. doi: 10.1002/ana.21364.

PMID:
18412121
13.

Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients.

van der Deure WM, Appelhof BC, Peeters RP, Wiersinga WM, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Visser TJ, Fliers E.

Clin Endocrinol (Oxf). 2008 Nov;69(5):804-11. doi: 10.1111/j.1365-2265.2008.03267.x. Epub 2008 Apr 10.

PMID:
18410547
14.

Autobiographical memory in the euthymic phase of recurrent depression.

Spinhoven P, Bockting CL, Schene AH, Koeter MW, Wekking EM, Williams JM.

J Abnorm Psychol. 2006 Aug;115(3):590-600.

PMID:
16866599
15.
16.

Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism.

Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, Wiersinga WM.

Eur J Endocrinol. 2005 Dec;153(6):747-53.

17.

Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy.

Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Fliers E.

J Clin Endocrinol Metab. 2005 Nov;90(11):6296-9. Epub 2005 Sep 6.

PMID:
16144953
18.

Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.

Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM.

J Clin Endocrinol Metab. 2005 May;90(5):2666-74. Epub 2005 Feb 10.

PMID:
15705921
19.

Elevated salivary dehydroepiandrosterone-sulfate but normal cortisol levels in medicated depressed patients: preliminary findings.

Assies J, Visser I, Nicolson NA, Eggelte TA, Wekking EM, Huyser J, Lieverse R, Schene AH.

Psychiatry Res. 2004 Sep 30;128(2):117-22.

PMID:
15488954
20.

Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash.

van Hout MS, Wekking EM, Berg IJ, Deelman BG.

Psychother Psychosom. 2003 Sep-Oct;72(5):235-44. Review.

PMID:
12920327
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk